VEDR01 Versa DR
Implantable Pulse Generator (IPG)
VEDR01 Versa DR
Information

Device Survival Probability

VEDR01_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr 11 yr 12 yr at 150.0 mo                
% Excluding Normal Battery Depletion 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0                
% Including Normal Battery Depletion 99.8 99.7 99.6 99.5 99.2 98.5 97.1 91.7 78.8 63.9 54.3 50.7 49.3                
#   100113 93306 86234 78259 70885 63810 55186 44153 29621 16648 7679 1891 170                
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Customer Communications For This Model

Information

Product Characteristics

Generator Type IPG
NBD Code DDDR
Max. Delivered Energy N/A
More
Connector Style IS-1 UNI/BI
Serial Number Prefix NWH, PWH
Mass 27.1 g
Volume 12.1 cc
Waveform N/A
X-Ray ID PWH, PWB
Hide this content
IS-1 UNI/BI
Information

Estimated Longevity

Amplitude Setting 500 Lead Ω 1000 Lead Ω
Low 2.5 V (A, RV) 7.4 | 9.1* 8.2 | 10.3*
Nominal 3.5 V (A, RV) 6.0 | 7.2* 7.4 | 9.0*
High 5.0 V (A, RV) 4.5 | 5.1* 6.0 | 7.0*
Footnote

*The second longevity numbers provided apply to the N-series Versa VEDR01 product. The N-series products have increased longevity because of improved electronic circuitry. Click on "Other Articles" for more information on the N-series longevity. Longevity estimates based on the following device usage. Pace/Sense Mode DDD ; Atrial Pulse Width 0.4 ms; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; EGM Prestorage ON ; Upper Sensing Rate 130 ppm; Atrial Percent Paced 100 %; EGM Prestorage ON Time 1 ; Atrial Fib Percent of Time 0 %Hide this content

Information

Distribution Data

US Market Release2006-07-17
CE Approval Date2005-09-20
Registered USA Implants118769
Estimated Active USA Implants55438
Normal Battery Depletions9803
US Market Release2006-07-17
CE Approval Date2005-09-20
Estimated WW Distribution176691
Normal Battery Depletions9836
Information

Malfunctions (USA)

Therapy Function Not Compromised 11
Electrical Component 7
Electrical Interconnect 2
Possible Early Battery Depletion 2
Therapy Function Compromised 13
Electrical Component 9
Other 4
Information

Malfunctions (WW)

Therapy Function Not Compromised 17
Electrical Component 13
Electrical Interconnect 2
Possible Early Battery Depletion 2
Therapy Function Compromised 17
Electrical Component 13
Other 4
Information

EOS Indication

Prolonged Service period is 3 months after RRT/ERI assuming 100% pacing at the listed parameter settings. Reprogramming of pacing parameters may reduce the duration of the prolonged service period.

Information

Recommended Replacement (RRT)

Telemetry indication. Rate and Mode change to 65 ppm and VVI (VOO/65 with magnet).

Data as of October 29, 2020

www.medtronic.com/productperformance 776050